263 related articles for article (PubMed ID: 22194927)
1. Blood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysis.
Wang J; Chen J; Chen X; Wang B; Li K; Bi J
PLoS One; 2011; 6(12):e28844. PubMed ID: 22194927
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance and role of lymphatic vessel invasion as a major prognostic implication in non-small cell lung cancer: a meta-analysis.
Wang J; Wang B; Zhao W; Guo Y; Chen H; Chu H; Liang X; Bi J
PLoS One; 2012; 7(12):e52704. PubMed ID: 23285161
[TBL] [Abstract][Full Text] [Related]
3. Lymphovascular invasion as a prognostic indicator in stage I non-small cell lung cancer: a systematic review and meta-analysis.
Mollberg NM; Bennette C; Howell E; Backhus L; Devine B; Ferguson MK
Ann Thorac Surg; 2014 Mar; 97(3):965-71. PubMed ID: 24424014
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of RASSF1A promoter hypermethylation in non-small cell lung carcinoma: a systematic review and meta-analysis.
Wang J; Wang B; Chen X; Bi J
Carcinogenesis; 2011 Mar; 32(3):411-6. PubMed ID: 21156971
[TBL] [Abstract][Full Text] [Related]
6. Proposal on incorporating blood vessel invasion into the T classification parts as a practical staging system for stage I non-small cell lung cancer.
Kudo Y; Saji H; Shimada Y; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
Lung Cancer; 2013 Aug; 81(2):187-93. PubMed ID: 23664031
[TBL] [Abstract][Full Text] [Related]
7. Proposal on incorporating lymphovascular invasion as a T-descriptor for stage I lung cancer.
Wang S; Zhang B; Qian J; Qiao R; Xu J; Zhang L; Zhao Y; Zhang Y; Wang R; Zhao R; Han B
Lung Cancer; 2018 Nov; 125():245-252. PubMed ID: 30429028
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of the frequency of vascular invasion in stage I non-small cell lung cancer.
Okada S; Mizuguchi S; Izumi N; Komatsu H; Toda M; Hara K; Okuno T; Shibata T; Wanibuchi H; Nishiyama N
Gen Thorac Cardiovasc Surg; 2017 Jan; 65(1):32-39. PubMed ID: 27738881
[TBL] [Abstract][Full Text] [Related]
9. Blood vessel invasion by tumor cells predicts recurrence in completely resected T1 N0 M0 non-small-cell lung cancer.
Macchiarini P; Fontanini G; Hardin MJ; Chuanchieh H; Bigini D; Vignati S; Pingitore R; Angeletti CA
J Thorac Cardiovasc Surg; 1993 Jul; 106(1):80-9. PubMed ID: 8391612
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of intratumoural microvascular invasion and microlymphatic permeation on node-negative non-small-cell lung cancer: which indicator is the stronger prognostic factor?
Hishida T; Yoshida J; Maeda R; Ishii G; Aokage K; Nishimura M; Nagai K
Eur J Cardiothorac Surg; 2013 Apr; 43(4):772-7. PubMed ID: 22864791
[TBL] [Abstract][Full Text] [Related]
11. Different biomarkers in non-small cell lung cancer in blood vessel invasion.
Zhang C; Liu Y; Guo S; Zhang J
Cell Biochem Biophys; 2014 Nov; 70(2):777-84. PubMed ID: 24801771
[TBL] [Abstract][Full Text] [Related]
12. Simple preoperative computed tomography image analysis shows good predictive performance for pathological vessel invasion in clinical stage IA non-small cell lung cancer.
Ito T; Murakawa T; Sato H; Tanabe A; Maekawa M; Yoshida Y; Fukayama M; Nakajima J
Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):633-8. PubMed ID: 22740516
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors for Local and Distant Recurrence After Surgical Treatment in Patients With Non-Small-Cell Lung Cancer.
Dziedzic DA; Rudzinski P; Langfort R; Orlowski T;
Clin Lung Cancer; 2016 Sep; 17(5):e157-e167. PubMed ID: 26831834
[TBL] [Abstract][Full Text] [Related]
14. Vascular invasion is an adverse prognostic factor in resected non-small-cell lung cancer.
Ramnefjell M; Aamelfot C; Helgeland L; Akslen LA
APMIS; 2017 Mar; 125(3):197-206. PubMed ID: 28233448
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of epigenetic silencing of p16 gene in NSCLC patients: a systematic review and meta-analysis.
Lou-Qian Z; Rong Y; Ming L; Xin Y; Feng J; Lin X
PLoS One; 2013; 8(1):e54970. PubMed ID: 23372805
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Liu X; Huang G; Zhang J; Zhang L; Liang Z
PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of microscopic vessel invasion and visceral pleural invasion in non-small cell lung cancer: a retrospective analysis of 2657 patients.
Neri S; Yoshida J; Ishii G; Matsumura Y; Aokage K; Hishida T; Nagai K
Ann Surg; 2014 Aug; 260(2):383-8. PubMed ID: 24646539
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of intratumoral blood vessel invasion in pathologic stage IA non-small cell lung cancer.
Shoji F; Haro A; Yoshida T; Ito K; Morodomi Y; Yano T; Maehara Y
Ann Thorac Surg; 2010 Mar; 89(3):864-9. PubMed ID: 20172144
[TBL] [Abstract][Full Text] [Related]
19. Pathological vascular invasion and tumor differentiation predict cancer recurrence in stage IA non-small-cell lung cancer after complete surgical resection.
Shimada Y; Saji H; Yoshida K; Kakihana M; Honda H; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
J Thorac Oncol; 2012 Aug; 7(8):1263-70. PubMed ID: 22673056
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor receptor 1 (IGF1R) expression and survival in non-small cell lung cancer patients: a meta-analysis.
Zhao S; Qiu Z; He J; Li L; Li W
Int J Clin Exp Pathol; 2014; 7(10):6694-704. PubMed ID: 25400749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
